These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved.
    Author: Fukushima M.
    Journal: Eicosanoids; 1990; 3(4):189-99. PubMed ID: 2073399.
    Abstract:
    PGD2 undergoes dehydration in aqueous media to form PGJ2 and in the presence of albumin they convert to delta 12-PGJ2. Delta 12-PGJ2 is one of the ultimate metabolites of PGD2 in human body fluids and is excreted in urine, approximately 152 ng/24 h for males and 66 ng/24 h for females. Delta 12-PGJ2 and also PGA2 are actively incorporated into cells and transferred to the nuclei. Both PGs lead to cell cycle arrest at G1 phase and inhibit viral replication at non-toxic doses. Several genes including myc oncogene family expressions are suppressed and several specific proteins, mainly the heat-shock protein family, are induced prior to G1 arrest or to inhibition of viral replication. Thus cyclopentenone PGs, i.e., PGJ and A series containing a reactive alpha, beta-unsaturated carbonyl constitute a different PG category from other classical PGs. Recently other biological activities of delta 12-PGJ2 such as immunomodulation and stimulated osteogenesis have been found. The author reviews PGJ2 research and introduces several new aspects.
    [Abstract] [Full Text] [Related] [New Search]